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STELLINGEN
Behorende bij het proefschrift
CHEK2 1100delC and polygenic susceptibility to breast cancer and colorectal cancer
1.	 CHEK2	1100delC	is	a	susceptibility	allele	for	HNPCC-related	colorectal	cancer	(this thesis).
2.	 The	CHEK2	1100delC	mutation	partakes	in	a	polygenic	cancer	model	that	additionally	involves		
	 at	least	one	breast	cancer	susceptibility	allele	and	at	least	one	colorectal	cancer	susceptibility		
	 allele (this thesis).
3.	 The	observation	that	p53	and	CHEK2	mutations	occur	mutual	exclusive	in	human	cancer	cell		
	 lines	suggests	that	the	abolished	function	of	the	encoded	proteins	results	in	similar	effects	on		
	 carcinogenesis	(this thesis).
4.	 MDM2	SNP309	and	MUTYH	Y179C,	G396D	and	P405L	do	not	play	a	major	role	in	the	polygenic		
	 CHEK2	cancer	model	(this thesis).
5.	 Comprehension	of	the	genotypic	and	phenotypic	characteristics	associated	with		
	 CHEK2	1100delC	cancer	families	and	CHEK2	1100delC	tumors	will	aid	the	identification	of	other		
	 risk	alleles	involved	in	the	polygenic	CHEK2	cancer	model	(this thesis).
6.	 A	1%	population	frequency	as	cutoff	for	pathogenicity	of	a	gene	variant	has	become	outdated		
	 since	the	discovery	of	CHEK2	1100delC	as	a	breast	cancer	susceptibility	allele.
7.	 The	difficulty	in	most	scientific	research	lies	not	in	the	experiments	themselves	but	in		
	 formulating	the	hypothesis	and	designing	the	study.
8.	 Recent	progress	has	been	made	in	mapping	the	DNA	sequence	associated	with	disease	but,		
	 like	early	world	maps,	many	crucial	details	remain	unclear	(P. Donnely, Nature 2008; 456:728-731).
9.	 Given	the	extensive	genotypic	and	phenotypic	heterogeneity	of	breast	cancer,	it	is	insufficient		
	 to	state	that	a	patient	is	diagnosed	with	breast	cancer	(H.T. Lynch et al., The Breast Journal  
 2008; 14:3-13).
10.  A	human	being	is	more	than	the	sum	of	its	genes.
11. Een	verre	vriend	is	beter	dan	een	goede	buur.
